The growth of malignant keratinocytes depends on signaling through the PGE2 receptor EP1

Eric J. Thompson, Ashok Gupta, George A. Vielhauer, John W Regan, G. Tim Bowden

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Recent discoveries shed light on the importance of prostaglandin (PG) production in the development of skin cancer. Work by Fischer et al. demonstrates that skin tumor promotion caused by ultraviolet B radiation can be decreased by up to 89% by blocking cyclooxygenase-2 (COX-2) with the drug Celecoxib. A similar study showed that Celecoxib can decrease new tumor formation by 44% in mice that already have tumors. These studies demonstrate the importance of COX-2 and PGs in the development of squamous cell carcinoma. We have explored growth signaling in a model of skin tumor progression. Because changes in PG production have been implicated in skin carcinogenesis, we examined this pathway. We found that malignant cell lines secrete more prostaglandin E2 (PGE2) than the parental cells. We observed increased expression of COX-1 and -2. We also found that these cells express the PGE2 receptors EP1 and EP4. When the cells are grown in the presence of indomethacin, the growth rate of the malignant cells is decreased. This effect can be reversed by addition of PGE2 or an EP1 agonist to the medium. Thus, we have shown that skin tumor cells depend in part on PGE2 signaling through the EP1 prostanoid receptor for their in vitro growth.

Original languageEnglish (US)
Pages (from-to)402-410
Number of pages9
JournalNeoplasia
Volume3
Issue number5
DOIs
StatePublished - 2001

Fingerprint

Prostaglandin Receptors
Keratinocytes
Dinoprostone
Celecoxib
Growth
Skin
Cyclooxygenase 2
Neoplasms
Prostaglandins
Receptors, Prostaglandin E, EP1 Subtype
Skin Neoplasms
Indomethacin
Squamous Cell Carcinoma
Carcinogenesis
Radiation
Cell Line
Pharmaceutical Preparations

Keywords

  • COX-1
  • COX-2
  • EP1
  • Keratinocyte growth
  • PGE
  • Tumor progression

ASJC Scopus subject areas

  • Cancer Research

Cite this

The growth of malignant keratinocytes depends on signaling through the PGE2 receptor EP1. / Thompson, Eric J.; Gupta, Ashok; Vielhauer, George A.; Regan, John W; Bowden, G. Tim.

In: Neoplasia, Vol. 3, No. 5, 2001, p. 402-410.

Research output: Contribution to journalArticle

Thompson, Eric J. ; Gupta, Ashok ; Vielhauer, George A. ; Regan, John W ; Bowden, G. Tim. / The growth of malignant keratinocytes depends on signaling through the PGE2 receptor EP1. In: Neoplasia. 2001 ; Vol. 3, No. 5. pp. 402-410.
@article{ca886107c49448fabdcff401b9cd67ca,
title = "The growth of malignant keratinocytes depends on signaling through the PGE2 receptor EP1",
abstract = "Recent discoveries shed light on the importance of prostaglandin (PG) production in the development of skin cancer. Work by Fischer et al. demonstrates that skin tumor promotion caused by ultraviolet B radiation can be decreased by up to 89{\%} by blocking cyclooxygenase-2 (COX-2) with the drug Celecoxib. A similar study showed that Celecoxib can decrease new tumor formation by 44{\%} in mice that already have tumors. These studies demonstrate the importance of COX-2 and PGs in the development of squamous cell carcinoma. We have explored growth signaling in a model of skin tumor progression. Because changes in PG production have been implicated in skin carcinogenesis, we examined this pathway. We found that malignant cell lines secrete more prostaglandin E2 (PGE2) than the parental cells. We observed increased expression of COX-1 and -2. We also found that these cells express the PGE2 receptors EP1 and EP4. When the cells are grown in the presence of indomethacin, the growth rate of the malignant cells is decreased. This effect can be reversed by addition of PGE2 or an EP1 agonist to the medium. Thus, we have shown that skin tumor cells depend in part on PGE2 signaling through the EP1 prostanoid receptor for their in vitro growth.",
keywords = "COX-1, COX-2, EP1, Keratinocyte growth, PGE, Tumor progression",
author = "Thompson, {Eric J.} and Ashok Gupta and Vielhauer, {George A.} and Regan, {John W} and Bowden, {G. Tim}",
year = "2001",
doi = "10.1038/sj.neo.7900182",
language = "English (US)",
volume = "3",
pages = "402--410",
journal = "Neoplasia",
issn = "1522-8002",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - The growth of malignant keratinocytes depends on signaling through the PGE2 receptor EP1

AU - Thompson, Eric J.

AU - Gupta, Ashok

AU - Vielhauer, George A.

AU - Regan, John W

AU - Bowden, G. Tim

PY - 2001

Y1 - 2001

N2 - Recent discoveries shed light on the importance of prostaglandin (PG) production in the development of skin cancer. Work by Fischer et al. demonstrates that skin tumor promotion caused by ultraviolet B radiation can be decreased by up to 89% by blocking cyclooxygenase-2 (COX-2) with the drug Celecoxib. A similar study showed that Celecoxib can decrease new tumor formation by 44% in mice that already have tumors. These studies demonstrate the importance of COX-2 and PGs in the development of squamous cell carcinoma. We have explored growth signaling in a model of skin tumor progression. Because changes in PG production have been implicated in skin carcinogenesis, we examined this pathway. We found that malignant cell lines secrete more prostaglandin E2 (PGE2) than the parental cells. We observed increased expression of COX-1 and -2. We also found that these cells express the PGE2 receptors EP1 and EP4. When the cells are grown in the presence of indomethacin, the growth rate of the malignant cells is decreased. This effect can be reversed by addition of PGE2 or an EP1 agonist to the medium. Thus, we have shown that skin tumor cells depend in part on PGE2 signaling through the EP1 prostanoid receptor for their in vitro growth.

AB - Recent discoveries shed light on the importance of prostaglandin (PG) production in the development of skin cancer. Work by Fischer et al. demonstrates that skin tumor promotion caused by ultraviolet B radiation can be decreased by up to 89% by blocking cyclooxygenase-2 (COX-2) with the drug Celecoxib. A similar study showed that Celecoxib can decrease new tumor formation by 44% in mice that already have tumors. These studies demonstrate the importance of COX-2 and PGs in the development of squamous cell carcinoma. We have explored growth signaling in a model of skin tumor progression. Because changes in PG production have been implicated in skin carcinogenesis, we examined this pathway. We found that malignant cell lines secrete more prostaglandin E2 (PGE2) than the parental cells. We observed increased expression of COX-1 and -2. We also found that these cells express the PGE2 receptors EP1 and EP4. When the cells are grown in the presence of indomethacin, the growth rate of the malignant cells is decreased. This effect can be reversed by addition of PGE2 or an EP1 agonist to the medium. Thus, we have shown that skin tumor cells depend in part on PGE2 signaling through the EP1 prostanoid receptor for their in vitro growth.

KW - COX-1

KW - COX-2

KW - EP1

KW - Keratinocyte growth

KW - PGE

KW - Tumor progression

UR - http://www.scopus.com/inward/record.url?scp=0034775863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034775863&partnerID=8YFLogxK

U2 - 10.1038/sj.neo.7900182

DO - 10.1038/sj.neo.7900182

M3 - Article

C2 - 11687951

AN - SCOPUS:0034775863

VL - 3

SP - 402

EP - 410

JO - Neoplasia

JF - Neoplasia

SN - 1522-8002

IS - 5

ER -